Characterization of imidazoline receptors in blood vessels for the development of antihypertensive agents

Mei Fen Chen, Jo Ting Tsai, Li Jen Chen, Tung Pi Wu, Jia Jang Yang, Li Te Yin, Yu Lin Yang, Tai An Chiang, Han Lin Lu, Ming Chang Wu

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

It has been indicated that activation of peripheral imidazoline Ireceptor (I-2R) may reduce the blood pressure in spontaneously hypertensive rats (SHRs). Also, guanidinium derivatives show the ability to activate imidazoline receptors. Thus, it is of special interest to characterize the I-2R using guanidinium derivatives in blood vessels for development of antihypertensive agent(s). Six guanidinium derivatives including agmatine, amiloride, aminoguanidine, allantoin, canavanine, and metformin were applied in this study. Western blot analysis was used for detecting the expression of imidazoline receptor in tissues of Wistar rats. The isometric tension of aortic rings isolated from male rats was also estimated. The expression of imidazoline receptor on rat aorta was identified. However, guanidinium derivatives for detection of aortic relaxation were not observed except agmatine and amiloride which induced a marked relaxation in isolated aortic rings precontracted with phenylephrine or KCl. Both relaxations induced by agmatine and amiloride were attenuated by glibenclamide at concentration enough to block ATP-sensitive potassium (KATP) channels. Meanwhile, only agmatine-induced relaxation was abolished by BU224, a selective antagonist of imidazoline Ireceptors. Taken together, we suggest that agmatine can induce vascular relaxation through activation of peripheral imidazoline Ireceptor to open KATP channels. Thus, agmatine-like compound has the potential to develop as a new therapeutic agent for hypertension in the future.

Original languageEnglish
Article number182846
JournalBioMed Research International
Volume2014
DOIs
Publication statusPublished - 2014

Fingerprint

Imidazoline Receptors
Agmatine
Blood vessels
Antihypertensive Agents
Blood Vessels
Guanidine
Imidazolines
KATP Channels
Rats
Amiloride
Derivatives
Canavanine
Chemical activation
Allantoin
Glyburide
Metformin
Blood pressure
Phenylephrine
Inbred SHR Rats
Aorta

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Medicine(all)

Cite this

Characterization of imidazoline receptors in blood vessels for the development of antihypertensive agents. / Chen, Mei Fen; Tsai, Jo Ting; Chen, Li Jen; Wu, Tung Pi; Yang, Jia Jang; Yin, Li Te; Yang, Yu Lin; Chiang, Tai An; Lu, Han Lin; Wu, Ming Chang.

In: BioMed Research International, Vol. 2014, 182846, 2014.

Research output: Contribution to journalArticle

Chen, Mei Fen ; Tsai, Jo Ting ; Chen, Li Jen ; Wu, Tung Pi ; Yang, Jia Jang ; Yin, Li Te ; Yang, Yu Lin ; Chiang, Tai An ; Lu, Han Lin ; Wu, Ming Chang. / Characterization of imidazoline receptors in blood vessels for the development of antihypertensive agents. In: BioMed Research International. 2014 ; Vol. 2014.
@article{140da398c8ce457db8144a3778e12e6d,
title = "Characterization of imidazoline receptors in blood vessels for the development of antihypertensive agents",
abstract = "It has been indicated that activation of peripheral imidazoline Ireceptor (I-2R) may reduce the blood pressure in spontaneously hypertensive rats (SHRs). Also, guanidinium derivatives show the ability to activate imidazoline receptors. Thus, it is of special interest to characterize the I-2R using guanidinium derivatives in blood vessels for development of antihypertensive agent(s). Six guanidinium derivatives including agmatine, amiloride, aminoguanidine, allantoin, canavanine, and metformin were applied in this study. Western blot analysis was used for detecting the expression of imidazoline receptor in tissues of Wistar rats. The isometric tension of aortic rings isolated from male rats was also estimated. The expression of imidazoline receptor on rat aorta was identified. However, guanidinium derivatives for detection of aortic relaxation were not observed except agmatine and amiloride which induced a marked relaxation in isolated aortic rings precontracted with phenylephrine or KCl. Both relaxations induced by agmatine and amiloride were attenuated by glibenclamide at concentration enough to block ATP-sensitive potassium (KATP) channels. Meanwhile, only agmatine-induced relaxation was abolished by BU224, a selective antagonist of imidazoline Ireceptors. Taken together, we suggest that agmatine can induce vascular relaxation through activation of peripheral imidazoline Ireceptor to open KATP channels. Thus, agmatine-like compound has the potential to develop as a new therapeutic agent for hypertension in the future.",
author = "Chen, {Mei Fen} and Tsai, {Jo Ting} and Chen, {Li Jen} and Wu, {Tung Pi} and Yang, {Jia Jang} and Yin, {Li Te} and Yang, {Yu Lin} and Chiang, {Tai An} and Lu, {Han Lin} and Wu, {Ming Chang}",
year = "2014",
doi = "10.1155/2014/182846",
language = "English",
volume = "2014",
journal = "BioMed Research International",
issn = "2314-6133",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Characterization of imidazoline receptors in blood vessels for the development of antihypertensive agents

AU - Chen, Mei Fen

AU - Tsai, Jo Ting

AU - Chen, Li Jen

AU - Wu, Tung Pi

AU - Yang, Jia Jang

AU - Yin, Li Te

AU - Yang, Yu Lin

AU - Chiang, Tai An

AU - Lu, Han Lin

AU - Wu, Ming Chang

PY - 2014

Y1 - 2014

N2 - It has been indicated that activation of peripheral imidazoline Ireceptor (I-2R) may reduce the blood pressure in spontaneously hypertensive rats (SHRs). Also, guanidinium derivatives show the ability to activate imidazoline receptors. Thus, it is of special interest to characterize the I-2R using guanidinium derivatives in blood vessels for development of antihypertensive agent(s). Six guanidinium derivatives including agmatine, amiloride, aminoguanidine, allantoin, canavanine, and metformin were applied in this study. Western blot analysis was used for detecting the expression of imidazoline receptor in tissues of Wistar rats. The isometric tension of aortic rings isolated from male rats was also estimated. The expression of imidazoline receptor on rat aorta was identified. However, guanidinium derivatives for detection of aortic relaxation were not observed except agmatine and amiloride which induced a marked relaxation in isolated aortic rings precontracted with phenylephrine or KCl. Both relaxations induced by agmatine and amiloride were attenuated by glibenclamide at concentration enough to block ATP-sensitive potassium (KATP) channels. Meanwhile, only agmatine-induced relaxation was abolished by BU224, a selective antagonist of imidazoline Ireceptors. Taken together, we suggest that agmatine can induce vascular relaxation through activation of peripheral imidazoline Ireceptor to open KATP channels. Thus, agmatine-like compound has the potential to develop as a new therapeutic agent for hypertension in the future.

AB - It has been indicated that activation of peripheral imidazoline Ireceptor (I-2R) may reduce the blood pressure in spontaneously hypertensive rats (SHRs). Also, guanidinium derivatives show the ability to activate imidazoline receptors. Thus, it is of special interest to characterize the I-2R using guanidinium derivatives in blood vessels for development of antihypertensive agent(s). Six guanidinium derivatives including agmatine, amiloride, aminoguanidine, allantoin, canavanine, and metformin were applied in this study. Western blot analysis was used for detecting the expression of imidazoline receptor in tissues of Wistar rats. The isometric tension of aortic rings isolated from male rats was also estimated. The expression of imidazoline receptor on rat aorta was identified. However, guanidinium derivatives for detection of aortic relaxation were not observed except agmatine and amiloride which induced a marked relaxation in isolated aortic rings precontracted with phenylephrine or KCl. Both relaxations induced by agmatine and amiloride were attenuated by glibenclamide at concentration enough to block ATP-sensitive potassium (KATP) channels. Meanwhile, only agmatine-induced relaxation was abolished by BU224, a selective antagonist of imidazoline Ireceptors. Taken together, we suggest that agmatine can induce vascular relaxation through activation of peripheral imidazoline Ireceptor to open KATP channels. Thus, agmatine-like compound has the potential to develop as a new therapeutic agent for hypertension in the future.

UR - http://www.scopus.com/inward/record.url?scp=84899539182&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899539182&partnerID=8YFLogxK

U2 - 10.1155/2014/182846

DO - 10.1155/2014/182846

M3 - Article

VL - 2014

JO - BioMed Research International

JF - BioMed Research International

SN - 2314-6133

M1 - 182846

ER -